Back to search

Article

Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid Leukemia

2025-10-15

Abstract excerpt

Mutations in the RAS/MAPK signaling pathway are recurrent in acute myeloid leukemia (AML), primarily involving NRAS and KRAS . In contrast, mutations in the gene encoding an effector protein, BRAF, occur at relatively lower frequencies in AML and are associated with poor outcomes. To date, no comprehensive analysis has assessed the clinical and molecular characteristics of BRAF- mutated AML. In this study, we r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bdbfbdac-05e3-566c-8e90-ec33c1968b90
DOI
10.1101/2025.10.14.682328
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic and Therapeutic Implications of <i>BRAF</i> Mutations in Acute Myeloid LeukemiaDOI 10.1101/2025.10.14.682328
Select a neighboring publication to make it the new centre.